19 November 2014
Curcumin with superior bioavailability
The unique NovaSOL® technology transforms curcumin into its most bioavailable form making it possible to create highly potent, small-dose products
While the beneficial properties of curcumin and its mechanism of action have been profoundly studied, its limited bioavailability is a major issue. Because of the low absorption of water insoluble compounds, a standard extract needs to be used in very high for efficacy. A unique technology that makes these compounds highly soluble has solved this problem.
The NovaSOL® solubilisation technology gives curcumin unique properties which result in a faster absorption, a very high bioavailability and longer lasting effect.
A human clinical trial shows the superior bioavailability of NovaSOL® Curcumin compared to a standard extract. This very stable, highly bioavailable solubilisate enhances the effect and the multiple health benefits of curcumin and is effective at much lower dosages. The material results in a clear yellow solution in both water and oil due to its unique micelle structure.
NovaSOL® Curcumin can be used in a broad variety of applications and products such as beverages or dietary supplements, especially soft gel capsules. Furthermore, the solubilisates are proven to be very stable and are ready for production use.
Dosage: 670 mg/day – equivalent to approx. 8 g standard curcumin 95%
• Curcuminoids: min. 6%
• Liquid curcumin solubilisate
• Unique solution with proprietary technology
• Fully water and fat soluble
• Clear coloured dissolution
• High bioavailability
• Supported by clinical data
The dried, powdered root of the turmeric plant has a long history of use in Ayurvedic treatment of various inflammatory conditions. Curcumin is well known for its potent antioxidant and anti-inflammatory properties and can play a vital role in the prevention of chronic inflammation which is linked to several conditions regarding joint health, brain health, gut and cardiovascular health.